封面
市場調查報告書
商品編碼
1449601

神經技術設備的全球市場:按產品類型、按條件、按最終用戶、按地區

Global Neurotech Devices Market, By Product Type, By Conditions, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年,全球神經技術設備市場價值為134.4億美元,2024年至2031年的年複合成長率(CAGR)為13.5%,預計2031年將達到370.4億美元。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 134.4億美元
實際資料 2019-2023 預測期 2024-2031
預測期間 2023/2024 至 2030/2031 年年複合成長率: 13.50% 2030/2031價值預測 370.4億美元
圖 1. 2024 年神經技術設備的全球市場佔有率(按地區分類)
全球神經科技設備市場-IMG1

神經技術設備旨在透過直接作用於神經系統來治療各種神經系統疾病。這些創新技術利用植入或穿戴式感測器和刺激器來收集神經資料,並可能修復大腦和脊髓中受損的途徑。傳統治療方法難以治療的疾病,如阿茲海默症、帕金森氏症、癲癇和慢性疼痛,可能會受益於有針對性的神經調節方法。全球神經技術設備市場仍處於早期階段,但隨著新產品進入臨床試驗,正在迅速成長。先進材料和電子設備的小型化使得創建生物相容性神經介面成為可能。提高公眾對神經系統疾病的認知以及增加政府對神經科學研究的支持是預計未來幾年推動該市場持續擴張的一些關鍵因素。

市場動態:

神經技術設備市場的推動因素包括全球神經系統疾病盛行率的上升、神經介面技術的進步、對微創治療的需求不斷成長以及政府對神經科學研究的資助不斷增加。然而,臨床試驗和產品開拓相關的高成本、新技術的報銷挑戰以及與長期設備植入相關的生物安全問題等因素對市場成長構成了重大挑戰。此外,各種新興企業和大公司開始探索神經技術在治療之外的應用,例如增強認知等領域,這提供了利潤豐厚的機會。研究人員、醫療設備公司和計算公司之間的合作將進一步加速下一代神經技術解決方案的開發。

本研究的主要特點

  • 該報告對全球神經技術設備市場進行了詳細分析,並提供了以2023年為基準年的預測期(2024-2031)的市場規模和年複合成長率(CAGR%)。
  • 它還說明了各個細分市場的潛在收益成長機會,並為該市場提供了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數,介紹了全球神經技術設備市場的主要企業。
  • 該報告的見解將幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 本研究報告針對該產業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球神經技術設備市場的各種策略矩陣,將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 神經系統疾病發生率增加
    • 將人工智慧和物聯網整合到神經技術設備中
    • 神經技術設備高成本
  • 主要亮點
  • 監管場景
  • 最近的趨勢
  • PEST分析
  • 波特的分析
  • 產品發表會
  • 合併、收購和合作

第4章全球神經技術設備市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章全球神經技術設備市場,依產品類型,2019-2031

  • 神經刺激
  • 神經刺激
  • 深部腦部刺激器
  • 胃電刺激設備
  • 脊髓刺激設備
  • 薦骨神經刺激器
  • 迷走神經刺激設備
  • 經皮神經電刺激 (TENS)
  • 其他神經刺激
  • 人工替代物
  • 神經感應
  • 神經復健裝置

第6章 2019-2031 年全球神經技術設備市場(按情況)

  • 疼痛管理
  • 認知障礙
  • 癲癇
  • 尿失禁和大便失禁
  • 聽力狀況
  • 帕金森氏症
  • 憂鬱症
  • 睡眠失調
  • 自發性震顫
  • 其他條件

第 7 章 全球神經技術設備市場,依最終使用者分類,2019-2031 年

  • 醫院
  • 門診手術中心
  • 居家護理設施
  • 其他最終用戶

第8章全球神經技術設備市場(按地區),2019-2031

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭格局

  • 公司簡介
    • Boston Scientific Corporation
    • BrainCo, Inc
    • Cochlear Limited
    • Control Bionics, Inc
    • LivaNova PLC
    • Medtronic plc
    • Nihon Kohden Corporation
    • Natus medical Incorporated
    • Integra LifeSciences
    • Blackrock Microsystems
    • NeuroSigma, Inc.
    • NeuroVigil Inc.
    • Neuralink Corp.
    • Abbott Laboratories
    • Advanced Bionics AG

第10章

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6629

The global neurotech devices market was valued US$ 13.44 Bn in 2023 and is expected to reach US$ 37.04 Bn by 2031 growing at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 13.44 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 13.50% 2030/2031 Value Projection: US$ 37.04 Bn
Figure 1. Global Neurotech Devices Market Share (%), By Region, 2024
Global Neurotech Devices Market - IMG1

Neurotech devices aim to treat a variety of neurological disorders by interfacing directly with the nervous system. These innovative technologies utilize implantable or wearable sensors and stimulating devices to collect neural data and potentially repair damaged pathways in the brain or spinal cord. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and chronic pain that have proved difficult to treat with conventional therapies may potentially benefit from targeted neuromodulation approaches. The global neurotech devices market is still at a nascent stage but growing rapidly as new products enter clinical trials. Advanced materials and miniaturization of electronics have enabled the creation of biocompatible neural interfaces. Rising public awareness about neurological illnesses and growing government support for neuroscience research are some of the key factors anticipated to drive continued expansion of this market in the coming years.

Market Dynamics:

The neurotech devices market is driven by the rising global prevalence of neurological disorders, technological advancements in neural interfaces, growing demand for minimally invasive therapies, and increasing government funding for neuroscience research. However, factors such as high costs associated with clinical trials and product development, reimbursement challenges for new technologies, and biosafety concerns pertaining to long term device implantation pose significant challenges to market growth. Various startups and large companies have also started exploring applications of neurotech beyond therapeutics, in areas like augmented cognition, which presents lucrative commercial opportunities. Collaborations between researchers, medical device firms, and computing companies are likely to further accelerate the development of next-generation neurotech solutions.

Key features of the study:

  • This report provides an in-depth analysis of the global neurotech devices market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global neurotech devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Boston Scientific Corporation, BrainCo, Inc, Cochlear Limited, Control Bionics, Inc, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Natus medical Incorporated, Integra LifeSciences, Blackrock Microsystems, NeuroSigma, Inc., NeuroVigil Inc., Neuralink Corp., Abbott Laboratories, and Advanced Bionics AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global neurotech devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurotech devices market.

Detailed Segmentation:

  • Global Neurotech Devices Market, By Product Type
    • Neurostimulation
    • Deep brain stimulator
    • Gastric electric stimulator
    • Spinal cord stimulator
    • Sacral nerve stimulator
    • Vagus nerve stimulator
    • Transcutaneous electrical nerve stimulation (TENS)
    • Other neurostimulations
    • Neuroprostheses
    • Neurosensing
    • Neurorehabilitation devices
  • Global Neurotech Devices Market, By Conditions
    • Pain management
    • Cognitive disorders
    • Epilepsy
    • Urinary and fecal incontinence
    • Hearing conditions
    • Parkinson's disease
    • Depression
    • Sleep disorders
    • Essential tremor
    • Other conditions
  • Global Neurotech Devices Market, By End User
    • Hospitals
    • Ambulatory surgical centers
    • Homecare facilities
    • Other end users
  • Global Neurotech Devices Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in the Global Neurotech Devices Market:
    • Boston Scientific Corporation
    • BrainCo, Inc
    • Cochlear Limited
    • Control Bionics, Inc
    • LivaNova PLC
    • Medtronic plc
    • Nihon Kohden Corporation
    • Natus medical Incorporated
    • Integra LifeSciences
    • Blackrock Microsystems
    • NeuroSigma, Inc.
    • NeuroVigil Inc.
    • Neuralink Corp.
    • Abbott Laboratories
    • Advanced Bionics AG

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Conditions
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising incidence of neurological disorders
    • Integration of AI & IoT in neurotech devices
    • High cost of neurotech devices
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Product Launches
  • Mergers, Acquisitions, and Collaborations

4. Global Neurotech Devices Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Neurotech Devices Market, By Product Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Neurostimulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Neurostimulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Deep brain stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Gastric electric stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Spinal cord stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Sacral nerve stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Vagus nerve stimulator
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Transcutaneous electrical nerve stimulation (TENS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other neurostimulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Neuroprostheses
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Neurosensing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Neurorehabilitation devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Neurotech Devices Market, By Conditions, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pain management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Cognitive disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Epilepsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Urinary and fecal incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Hearing conditions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Parkinson's disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Sleep disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Essential tremor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other conditions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Neurotech Devices Market, By End User, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Ambulatory surgical centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Homecare facilities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other end users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Neurotech Devices Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020 - 2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profile
    • Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • BrainCo, Inc
    • Cochlear Limited
    • Control Bionics, Inc
    • LivaNova PLC
    • Medtronic plc
    • Nihon Kohden Corporation
    • Natus medical Incorporated
    • Integra LifeSciences
    • Blackrock Microsystems
    • NeuroSigma, Inc.
    • NeuroVigil Inc.
    • Neuralink Corp.
    • Abbott Laboratories
    • Advanced Bionics AG

Analyst Views

10. Section

  • References
  • Research Methodology
  • About us